Journal ArticleCirc Res · July 5, 2024
BACKGROUND: Heart failure (HF) is one of the leading causes of mortality worldwide. Extracellular vesicles, including small extracellular vesicles or exosomes, and their molecular cargo are known to modulate cell-to-cell communication during multiple cardi ...
Full textLink to itemCite
Journal ArticleNPJ Regen Med · April 29, 2024
Historically, a lower incidence of cardiovascular diseases (CVD) and related deaths in women as compared with men of the same age has been attributed to female sex hormones, particularly estrogen and its receptors. Autologous bone marrow stem cell (BMSC) c ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 21, 2023
Background The mitochondrial mRNA-binding protein FASTKD1 (Fas-activated serine/threonine [FAST] kinase domain-containing protein 1) protects myocytes from oxidative stress in vitro. However, the role of FASTKD1 in the myocardium in vivo is unknown. Theref ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Mol Cell Cardiol · June 2022
Mitochondrial calcium (mCa2+) uptake couples changes in cardiomyocyte energetic demand to mitochondrial ATP production. However, excessive mCa2+ uptake triggers permeability transition and necrosis. Despite these established roles during acute stress, the ...
Full textOpen AccessLink to itemCite
Journal ArticleCardiovasc Res · January 7, 2022
AIMS: Myocardial infarction (MI) is the most common cause of heart failure (HF) worldwide. G protein-coupled receptor kinase 5 (GRK5) is upregulated in failing human myocardium and promotes maladaptive cardiac hypertrophy in animal models. However, the rol ...
Full textOpen AccessLink to itemCite
Journal ArticleTheranostics · 2022
Background and Purpose: Myocardial infarction (MI) in diabetic patients results in higher mortality and morbidity. We and others have previously shown that bone marrow-endothelial progenitor cells (EPCs) promote cardiac neovascularization and attenuate isc ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation Research · September 3, 2021
Introduction:
Cardiovascular diseases are the leading causes of death worldwide. After myocardial infarction (MI), there is a permanent loss of cardiomyocytes (CMs), and as the mammalian heart has lim ...
Full textCite
Journal ArticleJ Mol Cell Cardiol · May 2021
G protein-coupled receptor (GPCR) kinase 2 (GRK2) expression and activity are elevated early on in response to several forms of cardiovascular stress and are a hallmark of heart failure. Interestingly, though, in addition to its well-characterized role in ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Heart Circ Physiol · April 1, 2021
Recent data supporting any benefit of stem cell therapy for ischemic heart disease have suggested paracrine-based mechanisms via extracellular vesicles (EVs) including exosomes. We have previously engineered cardiac-derived progenitor cells (CDCs) to expre ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Signal · March 30, 2021
Aberrant changes in gene expression underlie the pathogenesis and progression of pressure-overload heart failure, leading to maladaptive cardiac hypertrophy, ventricular remodeling, and contractile dysfunction. Signaling through the G protein Gq triggers m ...
Full textOpen AccessLink to itemCite
Journal ArticleFront Immunol · 2021
Cardiac fibrosis, a pathological condition due to excessive extracellular matrix (ECM) deposition in the myocardium, is associated with nearly all forms of heart disease. The processes and mechanisms that regulate cardiac fibrosis are not fully understood. ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · September 2020
BACKGROUND: Cardiac hypertrophic growth is mediated by robust changes in gene expression and changes that underlie the increase in cardiomyocyte size. The former is regulated by RNA polymerase II (pol II) de novo recruitment or loss; the latter involves in ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Physiol Heart Circ Physiol · May 1, 2020
Nitric oxide (NO) and S-nitrosothiol (SNO) are considered cardio- and vasoprotective substances. We now understand that one mechanism in which NO/SNOs provide cardiovascular protection is through their direct inhibition of cardiac G protein-coupled recepto ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Res · January 31, 2020
Rationale: Systemic inflammation compromises the reparative properties of endothelial progenitor cell (EPC) and their exosomes on myocardial repair, although the underlying mechanism of loss of function of exosomes from inflamed EPCs is still obscure. Obje ...
Full textOpen AccessLink to itemCite
Journal ArticleJCI Insight · July 9, 2019
Podoplanin, a small mucine-type transmembrane glycoprotein, has been recently shown to be expressed by lymphangiogenic, fibrogenic and mesenchymal progenitor cells in the acutely and chronically infarcted myocardium. Podoplanin binds to CLEC-2, a C-type le ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Signal · December 11, 2018
Increased abundance of GRK2 [G protein-coupled receptor (GPCR) kinase 2] is associated with poor cardiac function in heart failure patients. In animal models, GRK2 contributes to the pathogenesis of heart failure after ischemia-reperfusion (IR) injury. In ...
Full textOpen AccessLink to itemCite
ConferenceCirculation Research · August 3, 2018
Cardiac contractility is regulated by the intracellular Ca
2+
concentration fluxes which are maintained by multiple channels and transporters. Mitochondrial Calcium Uniporter (MCU) is the hi ...
Full textCite
ConferenceCirculation Research · August 3, 2018
Our published studies, using TNFR1 and TNFR2 knockout (KO) mice have demonstrated that negative effects of TNF during ischemic tissue repair including enhanced apoptosis and inflammatory cytokines expression and signaling, is largely mediated by TN ...
Full textCite
Journal ArticleJ Mol Cell Cardiol · November 2017
Noonan Syndrome with Multiple Lentigines (NSML) is associated with congenital heart disease in form of pulmonary valve stenosis and hypertrophic cardiomyopathy (HCM). Genetically, NSML is primarily caused by mutations in the non-receptor protein tyrosine p ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation Research · July 22, 2016
Since the inability of the heart to adapt to pathological stress results in heart failure, supporting cardiac stress adaptation may improve clinical outcome. We hypothesized that the protein tyrosine phosphatase SHP2 controls adaptation by modulati ...
Full textCite
Journal ArticleJ Surg Res · February 2016
BACKGROUND: Placenta and amnion have been suggested as sources of juvenile cells and tissues for use in surgical regenerative medicine. We previously determined the impact of amniotic epithelial cells induced to undergo epithelial-to-mesenchymal transition ...
Full textOpen AccessLink to itemCite
Journal ArticleCell Transplant · 2015
The amniotic epithelium consists of cells exhibiting mature epithelial cell characteristics, but also varying degrees of stemness. We tested the hypothesis that induction of epithelial-to-mesenchymal transition (EMT) in amniotic epithelial cells (AECs) der ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Surg Res · November 2013
BACKGROUND: Autologous cells for cell therapy of ischemic cardiomyopathy often display age- and disease-related functional impairment, whereas an allogenic immunotolerant cell product would allow off-the-shelf application of uncompromised donor cells. We i ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Transl Med · September 27, 2013
BACKGROUND: Clinical cardiac cell therapy using autologous somatic stem cells is restricted by age and disease-associated impairment of stem cell function. Juvenile cells possibly represent a more potent alternative, but the impact of patient-related varia ...
Full textOpen AccessLink to itemCite